Meropenem Continuous Infusion in a Septic Patient with Periprosthetic Infection and End-Stage Renal Disease Undergoing Prolonged Intermittent Renal Replacement Therapy

This case report highlights the use of continuous infusion of meropenem in a 42-year-old septic female patient with periprosthetic infection and end-stage renal disease receiving prolonged intermittent renal replacement therapy (PIRRT). Antibiotic infusion in patients receiving renal replacement the...

Full description

Saved in:
Bibliographic Details
Main Authors: Assiya Kadralinova, Maiya Konkayeva, Serik Dzhandayev, Aidos Konkayev
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/61/1/63
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587977784557568
author Assiya Kadralinova
Maiya Konkayeva
Serik Dzhandayev
Aidos Konkayev
author_facet Assiya Kadralinova
Maiya Konkayeva
Serik Dzhandayev
Aidos Konkayev
author_sort Assiya Kadralinova
collection DOAJ
description This case report highlights the use of continuous infusion of meropenem in a 42-year-old septic female patient with periprosthetic infection and end-stage renal disease receiving prolonged intermittent renal replacement therapy (PIRRT). Antibiotic infusion in patients receiving renal replacement therapy has its own peculiarities. There are many studies on the optimal dosing regimen for meropenem in renal dysfunction, but studies on the optimal infusion duration in these patients are limited. The patient was admitted with complaints of wounds, necrosis zones of the right upper limb, restriction of joint movements, and temperature increase up to 38 °C. The patient was treated with a continuous infusion of meropenem 2 g per day receiving renal replacement therapy three times a week (12 h). Also during hospitalization, the patient underwent hip disarticulation and excision of necrotic tissues. The patient was further transferred to a specialized nephrology department for further treatment. We believe that in this clinical case, the use of continuous infusion of meropenem in the complex therapy of sepsis in a patient with CKD undergoing PIRRT sessions helped to lead to clinical improvement in the patient. Further studies are needed.
format Article
id doaj-art-232b9f3c5cb04474ba58358272ba2b40
institution Kabale University
issn 1010-660X
1648-9144
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj-art-232b9f3c5cb04474ba58358272ba2b402025-01-24T13:40:26ZengMDPI AGMedicina1010-660X1648-91442025-01-016116310.3390/medicina61010063Meropenem Continuous Infusion in a Septic Patient with Periprosthetic Infection and End-Stage Renal Disease Undergoing Prolonged Intermittent Renal Replacement TherapyAssiya Kadralinova0Maiya Konkayeva1Serik Dzhandayev2Aidos Konkayev3Department of Anesthesiology and Intensive Care, Astana Medical University, Astana 010000, KazakhstanDepartment of Anesthesiology and Intensive Care, National Scientific Center of Traumatology and Orthopedics Named After Academician N.D. Batpenov, Astana 010000, KazakhstanDepartment of Ear, Nose, Throat Diseases, Astana Medical University, Astana 010000, KazakhstanDepartment of Anesthesiology and Intensive Care, Astana Medical University, Astana 010000, KazakhstanThis case report highlights the use of continuous infusion of meropenem in a 42-year-old septic female patient with periprosthetic infection and end-stage renal disease receiving prolonged intermittent renal replacement therapy (PIRRT). Antibiotic infusion in patients receiving renal replacement therapy has its own peculiarities. There are many studies on the optimal dosing regimen for meropenem in renal dysfunction, but studies on the optimal infusion duration in these patients are limited. The patient was admitted with complaints of wounds, necrosis zones of the right upper limb, restriction of joint movements, and temperature increase up to 38 °C. The patient was treated with a continuous infusion of meropenem 2 g per day receiving renal replacement therapy three times a week (12 h). Also during hospitalization, the patient underwent hip disarticulation and excision of necrotic tissues. The patient was further transferred to a specialized nephrology department for further treatment. We believe that in this clinical case, the use of continuous infusion of meropenem in the complex therapy of sepsis in a patient with CKD undergoing PIRRT sessions helped to lead to clinical improvement in the patient. Further studies are needed.https://www.mdpi.com/1648-9144/61/1/63infectionmeropenem continuous infusionsepsisPIRRTend-stage kidney diseasecase report
spellingShingle Assiya Kadralinova
Maiya Konkayeva
Serik Dzhandayev
Aidos Konkayev
Meropenem Continuous Infusion in a Septic Patient with Periprosthetic Infection and End-Stage Renal Disease Undergoing Prolonged Intermittent Renal Replacement Therapy
Medicina
infection
meropenem continuous infusion
sepsis
PIRRT
end-stage kidney disease
case report
title Meropenem Continuous Infusion in a Septic Patient with Periprosthetic Infection and End-Stage Renal Disease Undergoing Prolonged Intermittent Renal Replacement Therapy
title_full Meropenem Continuous Infusion in a Septic Patient with Periprosthetic Infection and End-Stage Renal Disease Undergoing Prolonged Intermittent Renal Replacement Therapy
title_fullStr Meropenem Continuous Infusion in a Septic Patient with Periprosthetic Infection and End-Stage Renal Disease Undergoing Prolonged Intermittent Renal Replacement Therapy
title_full_unstemmed Meropenem Continuous Infusion in a Septic Patient with Periprosthetic Infection and End-Stage Renal Disease Undergoing Prolonged Intermittent Renal Replacement Therapy
title_short Meropenem Continuous Infusion in a Septic Patient with Periprosthetic Infection and End-Stage Renal Disease Undergoing Prolonged Intermittent Renal Replacement Therapy
title_sort meropenem continuous infusion in a septic patient with periprosthetic infection and end stage renal disease undergoing prolonged intermittent renal replacement therapy
topic infection
meropenem continuous infusion
sepsis
PIRRT
end-stage kidney disease
case report
url https://www.mdpi.com/1648-9144/61/1/63
work_keys_str_mv AT assiyakadralinova meropenemcontinuousinfusioninasepticpatientwithperiprostheticinfectionandendstagerenaldiseaseundergoingprolongedintermittentrenalreplacementtherapy
AT maiyakonkayeva meropenemcontinuousinfusioninasepticpatientwithperiprostheticinfectionandendstagerenaldiseaseundergoingprolongedintermittentrenalreplacementtherapy
AT serikdzhandayev meropenemcontinuousinfusioninasepticpatientwithperiprostheticinfectionandendstagerenaldiseaseundergoingprolongedintermittentrenalreplacementtherapy
AT aidoskonkayev meropenemcontinuousinfusioninasepticpatientwithperiprostheticinfectionandendstagerenaldiseaseundergoingprolongedintermittentrenalreplacementtherapy